levamisole has been researched along with acyclovir in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Glick, M; Muzyka, BC | 1 |
| Srimuang, S; Tanphaichitra, D | 1 |
| Merigan, TC; Smith, CI | 1 |
| Carreño, V; Montaño, L; Torres, M | 1 |
2 review(s) available for levamisole and acyclovir
| Article | Year |
|---|---|
Therapeutic approaches to chronic hepatitis B.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Azathioprine; Chronic Disease; Guanine; Hepatitis B; Humans; Immunoglobulins; Interferons; Levamisole; Ribavirin; Transfer Factor; Vidarabine; Vidarabine Phosphate | 1982 |
[Treatment of chronic hepatitis B].
Topics: Acyclovir; BCG Vaccine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Humans; Interferons; Levamisole; Transfer Factor; Vidarabine; Vidarabine Phosphate | 1983 |
1 trial(s) available for levamisole and acyclovir
| Article | Year |
|---|---|
Efficacy of acyclovir combined with immunopotentiating agents in the treatment of varicella-zoster.
Topics: Acyclovir; Adjuvants, Immunologic; Adolescent; Adult; Aged; Dinitrochlorobenzene; Drug Therapy, Combination; Female; Herpes Zoster; Humans; Immunity, Cellular; Inosine; Inosine Pranobex; Levamisole; Male; Middle Aged; Random Allocation; Rosette Formation; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1987 |
5 other study(ies) available for levamisole and acyclovir
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Alternative therapies for major aphthous ulcers in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Topical; Adult; Anti-Inflammatory Agents; Humans; Hydrocortisone; Levamisole; Male; Middle Aged; Mouthwashes; Nystatin; Pentamidine; Stomatitis, Aphthous; Tetracycline; Triamcinolone; Zidovudine | 1992 |